Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke

Rongjun Zou, Dingwen Zhang, Lei Lv, Wanting Shi, Zijiao Song, Bin Yi, Bingjia Lai, Qian Chen, Songran Yang, Ping HuaJournal of Translational Medicine 2019 · DOI

TL;DR

This study uses bioinformatics to identify gene expression patterns associated with atrial fibrillation (AF) and stroke, revealing potential biomarkers and therapeutic targets for AF-related stroke. The research highlights specific genes (ZNF566, PDZK1IP1, ZFHX3, PITX2) and microRNAs (miR-27a-3p, miR-27b-3p, miR-494-3p) that could be crucial for understanding and treating this complex condition.

What Problem Does This Paper Address?

Atrial fibrillation (AF) is a common heart arrhythmia that significantly increases the risk of ischemic stroke. However, current methods for predicting stroke risk in AF patients have limitations, especially for those with subclinical or intermittent AF. The exact molecular mechanisms linking AF to stroke are not fully understood, hindering the development of targeted therapies. This paper aims to bridge this knowledge gap by performing a bioinformatic analysis to identify co-expressed genes and their regulatory networks that are implicated in both AF and stroke, with the goal of uncovering novel biomarkers and therapeutic targets.

Methods

The researchers employed a multi-faceted bioinformatic approach. They began by identifying differentially expressed genes (DEGs) in left atrial tissue from AF patients and blood samples from stroke patients using data from the Gene Expression Omnibus (GEO) database. These DEGs were then analyzed for protein-protein interactions (PPI) using the STRING database and visualized with Cytoscape. Functional enrichment analyses, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, were performed using DAVID and REACTOME databases to understand the biological roles of these DEGs. Additionally, they used various online tools (mirDIP, miRDB, TargetScan, DIANA Tools) to predict microRNA (miRNA) targets for the identified co-expressed DEGs, aiming to uncover regulatory relationships. Finally, the Comparative Toxicogenomics Database (CTD) was used to explore potential links between the identified genes and nervous system or cardiovascular diseases.

Datasets

The study utilized publicly available datasets from the Gene Expression Omnibus (GEO):

  • GSE79768: This dataset contains paired left atrial (LA) and right atrial (RA) tissue samples from patients with persistent AF or sinus rhythm (SR).
  • GSE58294: This dataset includes blood samples from patients who experienced cardioembolic stroke (collected at <3, 5, and 24 hours post-stroke) and control patients.

Key Insights and Ideas

  • Bridging AF and Stroke at the Gene Level: The study successfully identified overlapping sets of differentially expressed genes (co-DEGs) between AF and stroke, suggesting a shared molecular basis for these conditions. This is a crucial step in understanding how AF directly contributes to stroke.
  • Identifying Key Players: The research pinpointed specific genes that appear to be central to the AF-stroke connection. Notably, ZNF566, PDZK1IP1, ZFHX3, and PITX2 emerged as significant co-expressed DEGs, suggesting they could serve as novel biomarkers or therapeutic targets.
  • MicroRNA Regulation: The identification of potential miRNA regulators for these co-DEGs, particularly miR-27a-3p, miR-27b-3p, and miR-494-3p, opens up avenues for miRNA-based therapeutic strategies. These miRNAs might play a critical role in modulating the expression of genes involved in AF-related stroke.
  • Functional Pathways: The enrichment analyses revealed that pathways related to inflammatory response, immune response, ion channels, and neuronal regulation are significantly involved in both AF and stroke. This highlights the complex interplay of these biological processes in the pathogenesis of AF-related stroke.

Key Results

  • DEGs Identified: The study identified 489 DEGs in AF patients' left atrial specimens and a significant number of DEGs in stroke patients' blood samples at different time points (<3h: 265, 5h: 518, 24h: 592).
  • Co-DEGs: Four co-expressed DEGs (ZNF566, PDZK1IP1, ZFHX3, and PITX2) were identified as being particularly relevant to AF-related stroke.
  • Hub Genes: For AF, hub genes like LRRK2, CALM1, CXCR4, TLR4, CTNNB1, and CXCR2 were identified. For stroke, hub genes included CD19, FGF9, SOX9, GNGT1, and NOG.
  • miRNA Association: Specific miRNAs, notably miR-27a-3p, miR-27b-3p, and miR-494-3p, were predicted to target the identified co-DEGs, suggesting their potential role in AF-related stroke.

Limitations and Future Work

The authors acknowledge several limitations:

  • Microarray Data: The study relies on microarray data, which reflects gene expression levels. They note that gene expression doesn't always directly correlate with protein expression, so the identified biomarkers should be considered at the gene level for now.
  • Validation Needed: The findings require validation through in vitro and in vivo experiments, as well as larger prospective clinical studies. The authors mention that current in vivo/in vitro models for AF and stroke are still immature.

Future work could focus on validating the identified genes and miRNAs as biomarkers for AF-related stroke risk and exploring their therapeutic potential. Investigating the precise molecular mechanisms by which these genes and miRNAs contribute to the AF-stroke link would be a crucial next step.

Summary updated

Abstract

AF and stroke are related and ZNF566, PDZK1IP1, ZFHX3, and PITX2 genes are significantly associated with novel biomarkers involved in AF-related stroke.
BibTeX
@article{zou2019bioinformatic,
  author = {Rongjun Zou and Dingwen Zhang and Lei Lv and Wanting Shi and Zijiao Song and Bin Yi and Bingjia Lai and Qian Chen and Songran Yang and Ping Hua},
  title = {{Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke}},
  journal = {Journal of Translational Medicine},
  year = {2019},
  doi = {10.1186/s12967-019-1790-x},
}
Figure